Anti-ST2 (MSTT1041A)

MSTT1041A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-ST2 (MSTT1041A), covering 2022-05-24 to 2022-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) [Phase 2]